Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
2019 · The Lancet · 1,172 citations
https://doi.org/10.1016/s0140-6736(19)33041-7
M
Marc Bourlière
Inserm(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
651
Papers
26.2K
Citations
78
h-index
247
i10-index
Marc Bourlière is an academic researcher from Inserm. The author has contributed to research in topics: Hepatitis C virus research & Liver Disease Diagnosis and Treatment & Hepatitis B Virus Studies. The author has an h-index of 78, co-authored 554 publications.
ORCID: 0000-0001-8976-9200Papers by this author
worksAdvancing the global public health agenda for NAFLD: a consensus statement
2021 · Nature Reviews Gastroenterology & Hepatology · 709 citations
https://doi.org/10.1038/s41575-021-00523-4
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study
2019 · The Lancet · 617 citations
https://doi.org/10.1016/s0140-6736(18)32111-1
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
2023 · The Lancet · 415 citations
https://doi.org/10.1016/s0140-6736(23)01796-8
Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus
2005 · Comparative Hepatology · 150 citations
https://doi.org/10.1186/1476-5926-4-6
Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy
2019 · Gastroenterology · 129 citations
https://doi.org/10.1053/j.gastro.2018.11.053
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat